El Hospital General del Parc Sanitari Sant Joan de Déu el premio a Mejor Hospital en la categoría de enfermedades infecciosas. Se trata de un reconocimiento que reafirma la consolidación de este se...
Read moreDra. Raquel Abalo, Professor of Pharmacology, has been invited to two congresses to present some results of his research group Neugut. The researcher stressed that prolonged use and high doses of cann...
Read moreEste 10 de octubre se celebran lo días dedicados a estas patologías.
Read moreThe European Molecular Biology Laboratory (EMBL) and the Institute for Bioengineering of Catalonia (IBEC) aim to strengthen future collaboration between the two research institutions. With this purpos...
Read moreLow vision is the condition suffered by people whose eyesight is impaired to the extent that their daily tasks are hard to carry out. On the occasion of World Sight Day, the Barcelona Macula Foundatio...
Read moreLa flora que acompaña nuestros campos suele percibirse como una mala hierba porque, o bien compite con el cultivo, o bien porque dificulta los trabajos dentro de la finca. Ahora bien, «también pued...
Read moreEl Hospital Universitario Reina Sofía organiza un encuentro sobre la optimización del uso de opioides en el manejo del paciente quirúrgico y crítico. Se trata de una jornada de gran interés cient...
Read moreLa Asociación de Cirugía Pediátrica de Andalucía celebra la 15 edición de su congreso anual en el que se han presentado 40 comunicaciones orales
Read morePneumonia – a preventable disease – kills more children than any other infection
Read moreThe conference on health innovation Innovation for value, held on November 8 in Barcelona, has analyzed the opportunities offered by technological advances in the field of health. The conference, orga...
Read moreIn the last two months, Vytrus Biotech has been exhibiting at the most important events of the Cosmetic industry both locally and internationally such as In-Cosmetics LATAM in Brazil, In-Cosmetics Asi...
Read moreOryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a public clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with strong unmet medical needs, announc...
Read more